AGOMAB

Pharmaceutical and medical preparations; chemical preparations for medical and pharmaceutical purposes; pharmaceutical and medical preparations for use in relation to fibrosis, fibrotic diseases, fibrostenosing Crohn's disease, idiopathic pulmonary fibrosis, skin diseases, eye diseases, organ failure, liver disease, kidney disease, inflammatory disease, degenerative disease, autoimmune disease, and the treatment of diseases requiring tissue repair; small molecule drugs; antibodies; pharmaceutical and medical preparations incorporating antibodies.

Scientific research and development services; clinical trials; research and development in the fields of fibrosis, fibrotic diseases, fibrostenosing crohn's disease, idiopathic pulmonary fibrosis, skin diseases, eye diseases, organ failure, liver disease, kidney disease, inflammatory disease, degenerative disease, autoimmune disease, and the treatment of diseases requiring tissue repair; research and development in the fields of small molecules and antibodies; research, development and design of pharmaceutical and medical preparations; drug development and discovery services; laboratory and medical laboratory research and development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy, advisory and information services relating to all the aforesaid.